Accuracy of CREST Guideline in Management of Cellulitis in Emergency Department; a Systematic Review and Meta-analysis
Archives of Academic Emergency Medicine,
Vol. 9 No. 1 (2021),
1 January 2021
,
Page e69
https://doi.org/10.22037/aaem.v9i1.1422
Abstract
Introduction: Skin and soft tissue infections are important causes of outpatient visits to medical clinics or hospitals. This study aimed to review the literature for the accuracy of Clinical Resource Efficiency Support Team (CREST) guideline in management of cellulitis in emergency department.
Method: Studies that had evaluated cellulitis patients using the CREST guideline were quarried in Scopus, Web of Science, and PubMed database, from 2005 to the end of 2020. The quality of the studies was evaluated using Scottish Intercollegiate Guideline Network (SIGN) checklist for cohort studies. Pooled area under the receiver operating characteristic curve (AUROC) of CREST guideline regarding the rate of hospital stay more than 24 hours, rate of revisit, and appropriateness of antimicrobial treatment in management of cellulitis in emergency department was evaluated.
Results: Seven studies evaluating a total of 1640 adult cellulitis patients were finally entered to the study. In evaluation of the rate of the appropriate treatment versus over-treatment, the pooled AUROC was estimated to be 0.38 (95% confidence interval (CI): 0.06 – 0.82), indicating low accuracy (AUROC lower than 0.5) of guideline for antimicrobial choice. CREST II patients had a significantly lower odds ratio (OR) of revisiting the Emergency Department, OR=0.21 (95% CI: 0.009 – 0.47). Pooled AUROC value of 0.86 (CI95%: 0.84 – 0.89) showed accuracy of the CREST classification in prediction of being hospitalized more or less than 24 hours.
Conclusion: CREST classification shows good accuracy in determining the duration of hospitalization or observation in ED but it could lead to inevitable over/under treatment with empirical antimicrobial agents.
- Cellulitis
- emergency service, hospital
- systematic review
- skin diseases
- bacterial
- anti-bacterial agents
How to Cite
References
Bystritsky RJ. Cellulitis. Infectious Disease Clinics. 2021;35(1):49-60.
Norimatsu Y, Ohno Y. Predictors for readmission due to cellulitis among Japanese patients. The Journal of Dermatology. 2021;48(5):681-4.
Cranendonk D, Lavrijsen A, Prins J, Wiersinga W. Cellulitis: current insights into pathophysiology and clinical management. The Netherlands Journal of Medicine. 2017;75(9):366-78.
Koerner R, Johnson AP. Changes in the classification and management of skin and soft tissue infections. Journal of Antimicrobial Chemotherapy. 2011;66(2):232-4.
Fulton R, Doherty L, Gill D, Harney A, Harper C, Jenkinson H. Guidelines on the management of cellulitis in adults. Northern Ireland: CREST. 2005.
Vijayalakshmi B, Ganapathy D. Medical management of cellulitis. Research Journal of Pharmacy and Technology. 2016;9(11):2067-70.
Miller J. The Scottish intercollegiate guidelines network (SIGN). The British Journal of Diabetes & Vascular Disease. 2002;2(1):47-9.
Eng J. ROC analysis: web-based calculator for ROC curves. Baltimore: Johns Hopkins University. 2017 [updated 2014 March 19. Available from: http://www.jrocfit.org.
Marwick C, Broomhall J, McCowan C, Phillips G, Gonzalez-McQuire S, Akhras K, et al. Severity assessment of skin and soft tissue infections: cohort study of management and outcomes for hospitalized patients. Journal of Antimicrobial Chemotherapy. 2011;66(2):387-97.
Marwick C, Rae N, Irvine N, Davey P. Prospective study of severity assessment and management of acute medical admissions with skin and soft tissue infection. Journal of antimicrobial chemotherapy. 2012;67(4):1016-9.
Hashem NG, Hidayat L, Berkowitz L, Venugopalan V. Management of skin and soft-tissue infections at a community teaching hospital using a severity-of-illness tool. Journal of Antimicrobial Chemotherapy. 2016;71(11):3268-75.
Claeys KC, Lagnf AM, Patel TB, Jacob MG, Davis SL, Rybak MJ. Acute bacterial skin and skin structure infections treated with intravenous antibiotics in the emergency department or observational unit: experience at the Detroit Medical Center. Infectious diseases and therapy. 2015;4(2):173-86.
Claeys KC, Zasowski EJ, Lagnf AM, Sabagha N, Levine DP, Davis SL, et al. Development of a risk-scoring tool to determine appropriate level of care in acute bacterial skin and skin structure infections in an acute healthcare setting. Infectious diseases and therapy. 2018;7(4):495-507.
Abiri S, Foroughian M, Akbar H, Mehramiz NJ, Hatami N, Ameri AA, et al. The investigation of valid criteria for hospitalization and discharge in patients with limb cellulitis: a prospective cohort study. Journal of Emergency Practice and Trauma. 2020;6(2):55-8.
Parastan R, Kargar M, Solhjoo K, Kafilzadeh F. Staphylococcus aureus biofilms: Structures, antibiotic resistance, inhibition, and vaccines. Gene Reports. 2020;20:100739.
Moravvej Z, Estaji F, Askari E, Solhjou K, Naderi Nasab M, Saadat S. Update on the global number of vancomycin-resistant Staphylococcus aureus (VRSA) strains. International Journal of Antimicrobial Agents. 2013;42(4):370-1.
Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathogens and global health. 2015;109(7):309-18.
Abbasi M, Abiri S, Ghanbari M-J, Orimi MH. Evaluation of Crest Guideline Validity For Diagnosis of Non-facial Cellulites. Journal of Dermatologic Research and Therapy. 2016;1(2):05.
- Abstract Viewed: 1155 times
- PDF Downloaded: 554 times
